Your session is about to expire
← Back to Search
Intraocular Implant
Single Arm Treatment. for Presbyopia
Phase 4
Waitlist Available
Led By Mark E. Whitten, MD
Research Sponsored by Whitten Laser Eye
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
Study Summary
The objective of this study is to evaluate the Raindrop® Near Vision Inlay for the improvement of near vision in presbyopes implanted under a corneal flap or within a small-incision pocket.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Uncorrected Visual Acuity
Secondary outcome measures
Arcus Senilis
Trial Design
1Treatment groups
Experimental Treatment
Group I: Single Arm Treatment.Experimental Treatment1 Intervention
All patients will be unilaterally implanted in the non-dominant eye with the Raindrop Near Vision Inlay for the compensation of presbyopia.
Find a Location
Who is running the clinical trial?
Whitten Laser EyeLead Sponsor
1 Previous Clinical Trials
40 Total Patients Enrolled
1 Trials studying Presbyopia
40 Patients Enrolled for Presbyopia
Mark E. Whitten, MDPrincipal InvestigatorWhitten Laser Eye
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger